Risk minimization measures
Risk minimization measures
| Scientific Name | Brand name | Approval Date | Last Update | Details |
|---|---|---|---|---|
| Semaglutide | Ozempic, Tasylev, Wegovy, Rybelsus. | View | ||
| Lixisenatide | SOLIQUA SOLOSTAR | View | ||
| Tirzepatide | Mounjaro | View | ||
| Dulaglutide | Trulicity | View | ||
| Rivaroxaban | Rivaroxaban QO | View | ||
| Atropine sulphate | Atropine B. Braun | View | ||
| Botulinum Toxin Type A | Nabota | View | ||
| vandetanib | Caprelsa | View | ||
| Human Fibrinogen | Fibryga | View | ||
| bivalent, recombinant | ABRYSVO | View |